Skylight Health Group Inc., a healthcare platform focusing on transitioning patients into value-based care in the United States, has declared a dividend on its 9.25% Series A Cumulative Redeemable Perpetual Preferred Shares for January 2023. The Series A dividend will be payable in cash at $0.1927 per share on January 20, 2023, to shareholders of record as of December 30, 2022.<\/p>\n\n\n\n
In addition to the dividend declaration, Skylight Health Group also provided an update on its shares for debt transaction. The company will settle $438,400 in debt by issuing a total of 626,286 common shares to creditors at a deemed price of $0.70 per common share.<\/p>\n\n\n\n
Skylight Health Group focuses on positively impacting patient health outcomes and operates a U.S. multi-state primary care health network, offering a range of services from primary care to sub-specialty, allied health, and laboratory\/diagnostic testing. The company is dedicated to helping small and independent practices transition from a traditional fee-for-service model to value-based care through technology, data analytics, and infrastructure.<\/p>\n\n\n\n
About Skylight Health Group<\/em><\/strong><\/p>\n\n\n\n Skylight Health Group is a healthcare services and technology company that operates a U.S. multi-state primary care health network and focuses on transitioning patients into value-based care. The company offers a range of services from primary care to sub-specialty, allied health, and laboratory\/diagnostic testing, and it provides the tools and infrastructure to help practices shift from a traditional fee-for-service model to a value-based care model. The value-based care model focuses on quality over volume and aims to improve patient outcomes while reducing healthcare costs.<\/p>\n","protected":false},"excerpt":{"rendered":" Skylight Health Group Inc., a healthcare platform focusing on transitioning patients into value-based care in…<\/p>\n","protected":false},"author":1,"featured_media":145,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[5],"tags":[],"class_list":["post-144","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-news-and-updates"],"_links":{"self":[{"href":"https:\/\/medtechinnovate.com\/index.php\/wp-json\/wp\/v2\/posts\/144","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/medtechinnovate.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/medtechinnovate.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/medtechinnovate.com\/index.php\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/medtechinnovate.com\/index.php\/wp-json\/wp\/v2\/comments?post=144"}],"version-history":[{"count":1,"href":"https:\/\/medtechinnovate.com\/index.php\/wp-json\/wp\/v2\/posts\/144\/revisions"}],"predecessor-version":[{"id":146,"href":"https:\/\/medtechinnovate.com\/index.php\/wp-json\/wp\/v2\/posts\/144\/revisions\/146"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/medtechinnovate.com\/index.php\/wp-json\/wp\/v2\/media\/145"}],"wp:attachment":[{"href":"https:\/\/medtechinnovate.com\/index.php\/wp-json\/wp\/v2\/media?parent=144"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/medtechinnovate.com\/index.php\/wp-json\/wp\/v2\/categories?post=144"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/medtechinnovate.com\/index.php\/wp-json\/wp\/v2\/tags?post=144"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}